These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8912823)

  • 21. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
    Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B
    Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 and c-erbB-2 but not bcl-2 are predictive of metastasis-free survival in breast cancer patients receiving post-mastectomy adjuvant radiotherapy in Taiwan.
    Chen HH; Su WC; Guo HR; Chang TW; Lee WY
    Jpn J Clin Oncol; 2002 Sep; 32(9):332-9. PubMed ID: 12417598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer.
    Liu S; Edgerton SM; Moore DH; Thor AD
    Clin Cancer Res; 2001 Jun; 7(6):1716-23. PubMed ID: 11410511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins.
    Zhang GJ; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S
    Jpn J Clin Oncol; 1997 Dec; 27(6):371-7. PubMed ID: 9437997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients.
    Lê MG; Mathieu MC; Douc-Rasy S; Le Bihan ML; Adb El All H; Spielmann M; Riou G
    Int J Cancer; 1999 Dec; 84(6):562-7. PubMed ID: 10567899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma.
    Tang SC; Beck J; Murphy S; Chernenko G; Robb D; Watson P; Khalifa M
    Breast Cancer Res Treat; 2004 Apr; 84(3):203-13. PubMed ID: 15026618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
    Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
    Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.
    Kröger N; Milde-Langosch K; Riethdorf S; Schmoor C; Schumacher M; Zander AR; Löning T
    Clin Cancer Res; 2006 Jan; 12(1):159-68. PubMed ID: 16397038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
    Bánkfalvi A; Tory K; Kemper M; Breukelmann D; Cubick C; Poremba C; Füzesi L; Lellè RJ; Böcker W
    Pathol Res Pract; 2000; 196(7):489-501. PubMed ID: 10926327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl-2 protein expression and long-term survival in breast cancer.
    Joensuu H; Pylkkänen L; Toikkanen S
    Am J Pathol; 1994 Nov; 145(5):1191-8. PubMed ID: 7977649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
    BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer.
    Jansen RL; Joosten-Achjanie SR; Volovics A; Arends JW; Hupperets PS; Hillen HF; Schouten HC
    Anticancer Res; 1998; 18(6A):4455-62. PubMed ID: 9891509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bax immunohistochemical expression in breast carcinoma: a study with long term follow-up.
    Veronese S; Mauri FA; Caffo O; Scaioli M; Aldovini D; Perrone G; Galligioni E; Doglioni C; Dalla Palma P; Barbareschi M
    Int J Cancer; 1998 Feb; 79(1):13-8. PubMed ID: 9495351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
    Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
    Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer.
    Clahsen PC; van de Velde CJ; Duval C; Pallud C; Mandard AM; Delobelle-Deroide A; van den Broek L; Sahmoud TM; van de Vijver MJ
    J Clin Oncol; 1998 Feb; 16(2):470-9. PubMed ID: 9469330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.
    Caffo O; Doglioni C; Veronese S; Bonzanini M; Marchetti A; Buttitta F; Fina P; Leek R; Morelli L; Palma PD; Harris AL; Barbareschi M
    Clin Cancer Res; 1996 Sep; 2(9):1591-9. PubMed ID: 9816338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The expression of bcl-2, P53 and c-erbB-2 onco-proteins in breast cancer and their clinicopathological significance].
    Gao L; Ding H; Deng Y
    Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):165-8. PubMed ID: 9275673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas.
    Luna-Moré S; de los Santos F; Bretón JJ; Cañadas MA
    Pathol Res Pract; 1996 Jan; 192(1):27-32. PubMed ID: 8685038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of E-cadherin and bcl-2 on prognosis in patients with breast cancer.
    Kavgaci H; Yildiz B; Fidan E; Reis A; Ozdemir F; Cobanoglu U; Can G
    Bratisl Lek Listy; 2010; 111(9):493-7. PubMed ID: 21180263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients.
    Levesque MA; Katsaros D; Yu H; Giai M; Genta F; Roagna R; Ponzone R; Massobrio M; Sismondi P; Diamandis EP
    Int J Cancer; 1998 Apr; 79(2):147-52. PubMed ID: 9583729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.